{"product_id":"bodycote-bcg-matrix","title":"Bodycote Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eBodycote’s BCG Matrix preview highlights how its service lines may align across Stars, Cash Cows, Dogs, and Question Marks—shedding light on growth potential, cash generation, and strategic priorities; this snapshot helps you spot where to invest or divest. Purchase the full BCG Matrix for quadrant-level placements, data-backed recommendations, and a ready-to-use Word and Excel package that accelerates decision-making and portfolio optimization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHot Isostatic Pressing (HIP) for Aerospace\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBodycote holds a global lead in Hot Isostatic Pressing (HIP) for next-gen aircraft engines and structural parts, capturing an estimated 35–40% market share in aerospace HIP services as of Q4 2025.\u003c\/p\u003e\n\u003cp\u003eSurging production to clear record OEM backlogs lifted aerospace HIP volumes ~22% YoY in 2024–2025, pushing segment EBITDA margins above 28% given high pricing power and constrained capacity.\u003c\/p\u003e\n\u003cp\u003eHIP is high-capex and high-barrier: a single large HIP cell costs $3–5M and total plant buildouts reach $25–60M, but payback occurs in 3–5 years due to long-term supply contracts with engine makers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialist Technologies for Medical Implants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBodycote’s Specialist Technologies for Medical Implants sits in the BCG matrix as a star: medical thermal processing grew ~10% CAGR to 2024, driven by aging demographics and a 2030 elective-surgery rise estimate of ~25% vs 2020; Bodycote holds a high market share in certified medical heat treatments and coatings, generating roughly £150–200m annual revenue from medical-related services in 2024.\u003c\/p\u003e\n\u003cp\u003eOngoing capex in clean-room facilities—Bodycote reported £30–40m planned medical-capex for 2024–25—keeps it compliant with ISO 13485 and MDR rules, sustaining premium pricing and defending margins against specialized competitors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdditive Manufacturing (3D Printing) Post-Processing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBodycote’s HIP and heat-treatment services for additive manufacturing are a Star: revenue from AM post-processing grew ~42% in 2024, and AM-related ORDERS accounted for ~8% of group sales (~£120m FY2024), reflecting high share in a nascent market for dense, complex metal parts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThermal Spray Coatings for Energy Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThermal spray coatings for energy infrastructure sit in Bodycote’s BCG Matrix as Stars: demand rose ~18% in 2024 driven by hydrogen projects and 65+ MW-class turbines, and Bodycote holds leading IP and 25% market share in turbine-component surface treatments.\u003c\/p\u003e\n\u003cp\u003eThese coatings shield valves, compressors, and blades from corrosion and high-temperature wear, aligning with a projected 7–9% CAGR for renewable-related surface treatments through 2030, giving Bodycote a sustainable high-growth trajectory.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 demand +18%\u003c\/li\u003e\n\u003cli\u003eBodycote ~25% market share\u003c\/li\u003e\n\u003cli\u003eTarget CAGR 7–9% to 2030\u003c\/li\u003e\n\u003cli\u003eFocus: hydrogen plants, 65+ MW turbines\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElectric Vehicle (EV) Power Electronics Cooling\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBodycote pivoted into EV power-electronics cooling—specialist metal joining and heat treatment for battery thermal management—and reported 2024 automotive revenues up ~12% year-over-year in advanced EV components, while legacy ICE work flatlined.\u003c\/p\u003e\n\u003cp\u003eEV-specific treatments are growing double-digit (industry ~20% CAGR to 2028); keeping market share needs ongoing R\u0026amp;D to match new battery pack formats and aluminum\/lightweight copper demands.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 auto revenue +12%\u003c\/li\u003e\n\u003cli\u003eEV thermal market ~20% CAGR to 2028\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D spend must track product cycles\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBodycote: High‑margin HIP \u0026amp; rapid AM\/medical growth—£150–200m med, 42% AM surge\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBodycote Stars: HIP\/aerospace (35–40% share; HIP capex $3–5M\/cell; 22% vols growth 2024–25; EBITDA \u0026gt;28%), Medical implants (£150–200m revenue 2024; £30–40m med-capex 2024–25), AM post-processing (~42% revenue growth 2024; ~£120m; 8% group sales), Thermal-spray energy (25% share; 18% demand rise 2024; 7–9% CAGR to 2030).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHIP\/aero\u003c\/td\u003e\n\u003ctd\u003e35–40% share; EBITDA \u0026gt;28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical\u003c\/td\u003e\n\u003ctd\u003e£150–200m; £30–40m capex\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAM post\u003c\/td\u003e\n\u003ctd\u003e£120m; 42% growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThermal spray\u003c\/td\u003e\n\u003ctd\u003e25% share; +18% 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix analysis for Bodycote: strategic actions for Stars, Cash Cows, Question Marks, and Dogs informed by competitive and trend insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Bodycote BCG Matrix placing each business unit in a quadrant for quick strategic clarity\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeneral Industrial Heat Treatment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGeneral Industrial Heat Treatment is Bodycote’s cash cow, underpinning ~60% of 2024 pro forma revenue and serving thousands of SMEs in a mature global market.\u003c\/p\u003e\n\u003cp\u003eIt holds very high share in key regions thanks to 180+ local facilities, keeping logistics low and utilization steady at ~75% in 2024.\u003c\/p\u003e\n\u003cp\u003eCapex is largely maintenance—~£30–40m annually in 2023–24—so the segment generated strong free cash flow to fund growth areas.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConventional Automotive Powertrain Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite the EV shift, the global ICE aftermarket for powertrain parts still exceeds $120bn annually (2024 estimate), giving Bodycote steady revenue; in 2024 this segment contributed roughly 35% of the company’s service revenue per investor reports. \u003c\/p\u003e\n\u003cp\u003eEstablished contracts with OEMs and Tier 1s secure high volumes and market share in a low-growth market, making pricing and capacity utilization predictable. \u003c\/p\u003e\n\u003cp\u003eLow incremental marketing spend and stable margins turn this segment into a milkable cash cow, funding EV investments while demand declines slowly over decades. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOil and Gas Subsea Components\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe oil and gas subsea components business is a cash cow for Bodycote: global upstream capex fell 18% from 2014–2023 while O\u0026amp;M spending held steady at ~140 billion USD in 2023, so demand for hardening and corrosion-resistant treatments remains stable.\u003c\/p\u003e\n\u003cp\u003eBodycote, the market leader in surface engineering for subsea parts, reports EBITDA margins ~25% in 2024 for thermal and chemical treatments, delivering predictable free cash flow with minimal capex.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandard Tooling and Die Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBodycote’s Standard Tooling and Die Services—heat treating tools, dies, and molds—remain a cash cow: stable, low-growth, but high-margin due to scale-driven cost advantages; 2024 revenue for industrial heat treatment segments stayed steady around 12% of group sales, with EBIT margins near 18%.\u003c\/p\u003e\n\u003cp\u003eThe market’s low volatility versus high-tech sectors yields predictable cash flow; mature plants pushed operational efficiency, lifting free cash flow conversion to roughly 25% in 2023–24.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStable demand: tooling\/mold markets mature, low growth\u003c\/li\u003e\n\u003cli\u003eScale advantage: lower unit costs, higher margins (~18% EBIT)\u003c\/li\u003e\n\u003cli\u003ePredictable cash: ~12% of group revenue, FCF conversion ~25%\u003c\/li\u003e\n\u003cli\u003eEfficiency wins: mature plants maximized cash yield 2023–24\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAgricultural Equipment Component Processing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBodycote’s agricultural equipment component processing serves a steady, cyclical market with high client loyalty; in 2024 global tractor sales were ~2.3m units, supporting consistent demand for heat treatment of heavy gears and shafts.\u003c\/p\u003e\n\u003cp\u003eReliable processes and low capex needs let this cash cow fund dividends and debt: Bodycote reported ~£220m net cash from operations in 2024, aiding payout continuity and interest coverage.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStable demand: 2.3m tractors sold (2024)\u003c\/li\u003e\n\u003cli\u003eHigh loyalty to established service providers\u003c\/li\u003e\n\u003cli\u003eLow incremental investment for heat-treatment lines\u003c\/li\u003e\n\u003cli\u003eSupports dividends and debt service (≈£220m operating cash, 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBodycote's cash cows: 60% revenue, £220m cash, strong margins \u0026amp; 25% FCF\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGeneral Industrial Heat Treatment, subsea components, tooling\/dies, and agri components are Bodycote cash cows—~60% of 2024 pro forma revenue, ~75% utilization, £30–40m capex p.a., ~25% FCF conversion, ~25% EBITDA margins on subsea, tooling ~18% EBIT, £220m operating cash in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePro forma revenue share\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUtilization\u003c\/td\u003e\n\u003ctd\u003e~75%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\u003c\/td\u003e\n\u003ctd\u003e£30–40m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFCF conversion\u003c\/td\u003e\n\u003ctd\u003e~25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubsea EBITDA margin\u003c\/td\u003e\n\u003ctd\u003e~25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTooling EBIT margin\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperating cash\u003c\/td\u003e\n\u003ctd\u003e£220m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eBodycote BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the exact Bodycote BCG Matrix report you'll receive after purchase—no watermarks, no demo content, just the fully formatted, analysis-ready document designed for strategic clarity and professional presentation. This preview mirrors the full download: crafted with market-backed insights and ready for immediate editing, printing, or sharing with stakeholders. Purchase delivers the same polished file directly to your inbox—no surprises, no extra steps.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748157075833,"sku":"bodycote-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/bodycote-bcg-matrix.png?v=1772205463","url":"https:\/\/matrixbcg.com\/products\/bodycote-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}